×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateur : Pr Benoit You

18:30
Introduction
 
 
18:35
Prise en charge actuelle du cancer de l’ovaire et intérêt de KELIM
Pr Benoit You
 
18:55
Rôle des lymphocytes infiltrants tumoraux (TIL) et du score de réponse à la chimiothérapie (CRS)
Dr Pierre-Alexandre Just
 
19:15
Intérêt des tests HR et de RAD51
Dr Alexandra Leary
 
 
19:35
Applications pratiques des nouveaux outils et débat/discussion - Réponses aux questions
Ensemble des intervenants
 
  
Shooting date : 2022-05-18
Last update : 2022-05-20

Suggestions

Wednesday, January 22nd 2025 from 06pm to 07pm (GMT+1)
Honolulu : Wednesday, January 22nd 2025 from 06am to 07am (GMT+1)
San Francisco : Wednesday, January 22nd 2025 from 08am to 09am (GMT+1)
New York : Wednesday, January 22nd 2025 from 11am to 12pm (GMT+1)
Buenos Aires : Wednesday, January 22nd 2025 from 01pm to 02pm (GMT+1)
London / Dublin : Wednesday, January 22nd 2025 from 04pm to 05pm (GMT+1)
Paris / Berlin : Wednesday, January 22nd 2025 from 05pm to 06pm (GMT+1)
Istanbul : Wednesday, January 22nd 2025 from 06pm to 07pm (GMT+1)
Moscou / Dubaï : Wednesday, January 22nd 2025 from 08pm to 09pm (GMT+1)
Bangkok : Wednesday, January 22nd 2025 from 11pm to 12am (GMT+1)
Shanghai : Thursday, January 23rd 2025 from 12am to 01am (GMT+1)
Tokyo : Thursday, January 23rd 2025 from 01am to 02am (GMT+1)
Sydney : Thursday, January 23rd 2025 from 02am to 03am (GMT+1)
Wellington : Thursday, January 23rd 2025 from 04am to 05am (GMT+1)

Prise en charge des cancers de l'ovaire en rechute :

état des lieux et perspectives

Share
Monday, April 28th 2025 from 06:30pm to 07:30pm (GMT+2)
Honolulu : Monday, April 28th 2025 from 06:30am to 07:30am (GMT+2)
San Francisco : Monday, April 28th 2025 from 09:30am to 10:30am (GMT+2)
New York : Monday, April 28th 2025 from 12:30pm to 01:30pm (GMT+2)
Buenos Aires : Monday, April 28th 2025 from 01:30pm to 02:30pm (GMT+2)
Reykjavik : Monday, April 28th 2025 from 04:30pm to 05:30pm (GMT+2)
London / Dublin : Monday, April 28th 2025 from 05:30pm to 06:30pm (GMT+2)
Paris / Berlin : Monday, April 28th 2025 from 06:30pm to 07:30pm (GMT+2)
Istanbul : Monday, April 28th 2025 from 07:30pm to 08:30pm (GMT+2)
Moscou / Dubaï : Monday, April 28th 2025 from 08:30pm to 09:30pm (GMT+2)
Bangkok : Monday, April 28th 2025 from 11:30pm to 12:30am (GMT+2)
Shanghai : Tuesday, April 29th 2025 from 12:30am to 01:30am (GMT+2)
Tokyo : Tuesday, April 29th 2025 from 01:30am to 02:30am (GMT+2)
Sydney : Tuesday, April 29th 2025 from 03:30am to 04:30am (GMT+2)
Wellington : Tuesday, April 29th 2025 from 05:30am to 06:30am (GMT+2)

PARPi dans le cancer de l'ovaire en 1L

Données actuelles et perspectives pour la combinaison avec l’IO

Share
Tuesday, April 12th 2022 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, April 12th 2022 from 06am to 07:30am (GMT+2)
San Francisco : Tuesday, April 12th 2022 from 09am to 10:30am (GMT+2)
New York : Tuesday, April 12th 2022 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Tuesday, April 12th 2022 from 01pm to 02:30pm (GMT+2)
Reykjavik : Tuesday, April 12th 2022 from 04pm to 05:30pm (GMT+2)
London / Dublin : Tuesday, April 12th 2022 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Tuesday, April 12th 2022 from 06pm to 07:30pm (GMT+2)
Istanbul : Tuesday, April 12th 2022 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Tuesday, April 12th 2022 from 08pm to 09:30pm (GMT+2)
Bangkok : Tuesday, April 12th 2022 from 11pm to 12:30am (GMT+2)
Shanghai : Wednesday, April 13th 2022 from 12am to 01:30am (GMT+2)
Tokyo : Wednesday, April 13th 2022 from 01am to 02:30am (GMT+2)
Sydney : Wednesday, April 13th 2022 from 03am to 04:30am (GMT+2)
Wellington : Wednesday, April 13th 2022 from 05am to 06:30am (GMT+2)

Cancers séreux de bas grade

Share
Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, September 19th 2023 from 06am to 07:30am (GMT+2)
San Francisco : Tuesday, September 19th 2023 from 09am to 10:30am (GMT+2)
New York : Tuesday, September 19th 2023 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Tuesday, September 19th 2023 from 01pm to 02:30pm (GMT+2)
Reykjavik : Tuesday, September 19th 2023 from 04pm to 05:30pm (GMT+2)
London / Dublin : Tuesday, September 19th 2023 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
Istanbul : Tuesday, September 19th 2023 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Tuesday, September 19th 2023 from 08pm to 09:30pm (GMT+2)
Bangkok : Tuesday, September 19th 2023 from 11pm to 12:30am (GMT+2)
Shanghai : Wednesday, September 20th 2023 from 12am to 01:30am (GMT+2)
Tokyo : Wednesday, September 20th 2023 from 01am to 02:30am (GMT+2)
Sydney : Wednesday, September 20th 2023 from 03am to 04:30am (GMT+2)
Wellington : Wednesday, September 20th 2023 from 05am to 06:30am (GMT+2)

Prise en charge des carcinomes séreux de bas grade en 2023

Share
Scroll Up